A Symbol, at Least

At DrugMonkey, PhysioProf says "co-first authorship is a sham, and only serves as a political compromise to placate non-first authors" and that peer reviewers and academic committees "give little additional weight to the designation.” In the comments, TreeFish says, "The study section members who infer meaning from that are either (1) ignorant of the significance and approach of the paper; (2) petty; or (3) both." What do you say?

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.